A. Your doctor was correct that depression and suicidal thoughts do not appear in the official prescribing information for evolocumab (Repatha) or a similar drug, alirocumab (Praluent). Both are ...
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback